Probiotics can have an impact on feverish respiratory infections
06.2025
Author Dr. Martin Claßen, Bremen
Feverish respiratory infections, mostly caused by viruses, are one of the major issues at paediatric clinics in the winter months. Parents often ask for help, but apart from supportive measures, there is little that doctors can actively do.
A study was conducted in Milan on children aged between 28 days and 4 years to investigate whether a mix of probiotics, consisting of Bifidobacterium breve M-16V, Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001, can have an effect on the progression of these infections. The study looked at 128 patients immediately after they had visited Accident & Emergency and been diagnosed with a respiratory infection (69 male [54%]; average age 2.5 years). It was double-blind and randomised: over 14 days, 65 (51%) were given a placebo, and 63 were given a mix of probiotics.
The median duration of the fever was significantly lower in the probiotic group (3 days [IQR 2-4]) versus 5 days [IQR 4-6], making the adjusted risk rate 0.64 95% CI, 0.51-0.80). The group comparison showed no significant side effects.
Reference:
Bettocchi, S, Comotti, A, Elli, M, De Cosmi, V, Berti, C, Alberti, I, Mazzocchi, A, Rosazza, C, Agostoni, C, Milani, GP. Probiotics and Fever Duration in Children With Upper Respiratory Tract Infections: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(3):e250669. DOI: 10.1001/jamanetworkopen.2025.0669